Venclose Maven Catheter: payments to doctors
Payments that named Venclose Maven Catheter as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $715K
- Providers
- 2,272
- Transactions
- 5,811
- Average per transaction
- $123
The per-transaction average — $123 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,272 providers the average total is $315, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bard Peripheral Vascular, Inc. | $679,363 | 95.0% |
| BD | $34,906 | 4.9% |
| Davol Inc. | $525 | 0.1% |
| C. R. Bard, Inc. & Subsidiaries | $392 | 0.1% |